The present invention provides compounds of formula (I), compositions comprising such compounds； the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated)； and methods of treating patients with such compounds； wherein R5, R6, R7, R12, R13, A, L, B, n, W, X, Y and Z are as defined herein.
